BRIGHTCOVE (BCOV) Fundamental Analysis & Valuation

NASDAQ:BCOV • US10921T1016

4.45 USD
+0.01 (+0.23%)
At close: Feb 3, 2025
4.45 USD
0 (0%)
After Hours: 2/3/2025, 8:15:51 PM

This BCOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Taking everything into account, BCOV scores 3 out of 10 in our fundamental rating. BCOV was compared to 87 industry peers in the IT Services industry. The financial health of BCOV is average, but there are quite some concerns on its profitability. BCOV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. BCOV Profitability Analysis

1.1 Basic Checks

  • In the past year BCOV was profitable.
  • In the past year BCOV had a positive cash flow from operations.
  • In the past 5 years BCOV reported 4 times negative net income.
  • In the past 5 years BCOV always reported a positive cash flow from operatings.
BCOV Yearly Net Income VS EBIT VS OCF VS FCFBCOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

  • The Return On Assets of BCOV (-4.34%) is comparable to the rest of the industry.
  • BCOV has a Return On Equity (-9.58%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROIC N/A
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
BCOV Yearly ROA, ROE, ROICBCOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

  • BCOV has a Gross Margin of 61.60%. This is amongst the best in the industry. BCOV outperforms 81.01% of its industry peers.
  • In the last couple of years the Gross Margin of BCOV has remained more or less at the same level.
  • BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
BCOV Yearly Profit, Operating, Gross MarginsBCOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

4

2. BCOV Health Analysis

2.1 Basic Checks

  • BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BCOV has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BCOV Yearly Shares OutstandingBCOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BCOV Yearly Total Debt VS Total AssetsBCOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of 0.08, we must say that BCOV is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BCOV (0.08) is worse than 83.54% of its industry peers.
  • There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.08
ROIC/WACCN/A
WACC10.73%
BCOV Yearly LT Debt VS Equity VS FCFBCOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • BCOV has a Current Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of BCOV (0.75) is worse than 88.61% of its industry peers.
  • BCOV has a Quick Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BCOV has a Quick ratio of 0.75. This is amonst the worse of the industry: BCOV underperforms 88.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
BCOV Yearly Current Assets VS Current LiabilitesBCOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

3. BCOV Growth Analysis

3.1 Past

  • BCOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 145.45%, which is quite impressive.
  • Looking at the last year, BCOV shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
  • The Revenue has been growing slightly by 4.07% on average over the past years.
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 64.74% on average over the next years. This is a very strong growth
  • BCOV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.01% yearly.
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BCOV Yearly Revenue VS EstimatesBCOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BCOV Yearly EPS VS EstimatesBCOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 0.2 -0.2 0.4

3

4. BCOV Valuation Analysis

4.1 Price/Earnings Ratio

  • BCOV is valuated quite expensively with a Price/Earnings ratio of 89.00.
  • BCOV's Price/Earnings ratio is in line with the industry average.
  • BCOV is valuated expensively when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 124.65 indicates a quite expensive valuation of BCOV.
  • BCOV's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, BCOV is valued quite expensively.
Industry RankSector Rank
PE 89
Fwd PE 124.65
BCOV Price Earnings VS Forward Price EarningsBCOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BCOV.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as BCOV.
Industry RankSector Rank
P/FCF 51.96
EV/EBITDA 23.8
BCOV Per share dataBCOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • BCOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BCOV's earnings are expected to grow with 64.74% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

0

5. BCOV Dividend Analysis

5.1 Amount

  • No dividends for BCOV!.
Industry RankSector Rank
Dividend Yield N/A

BCOV Fundamentals: All Metrics, Ratios and Statistics

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-04
Earnings (Next)02-20
Inst Owners70.58%
Inst Owner Change0%
Ins Owners5.23%
Ins Owner Change0%
Market Cap201.05M
Revenue(TTM)199.83M
Net Income(TTM)-9.14M
Analysts45.71
Price Target4.54 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)56.43%
Max EPS beat(2)143.57%
EPS beat(4)4
Avg EPS beat(4)114.38%
Min EPS beat(4)56.43%
Max EPS beat(4)161.44%
EPS beat(8)6
Avg EPS beat(8)77.66%
EPS beat(12)10
Avg EPS beat(12)100.79%
EPS beat(16)14
Avg EPS beat(16)114.38%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)6
Avg Revenue beat(12)-0.14%
Revenue beat(16)10
Avg Revenue beat(16)0.35%
PT rev (1m)0%
PT rev (3m)14.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 89
Fwd PE 124.65
P/S 1.01
P/FCF 51.96
P/OCF 14.73
P/B 2.11
P/tB 11.84
EV/EBITDA 23.8
EPS(TTM)0.05
EY1.12%
EPS(NY)0.04
Fwd EY0.8%
FCF(TTM)0.09
FCFY1.92%
OCF(TTM)0.3
OCFY6.79%
SpS4.42
BVpS2.11
TBVpS0.38
PEG (NY)0.89
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.6%
FCFM 1.94%
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.16%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 186.6%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 0.08
F-Score7
WACC10.73%
ROIC/WACCN/A
Cap/Depr(3y)143.44%
Cap/Depr(5y)123.4%
Cap/Sales(3y)7.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year979.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.43%
OCF growth 3Y-40.43%
OCF growth 5Y12.05%

BRIGHTCOVE / BCOV FAQ

Can you provide the ChartMill fundamental rating for BRIGHTCOVE?

ChartMill assigns a fundamental rating of 3 / 10 to BCOV.


What is the valuation status for BCOV stock?

ChartMill assigns a valuation rating of 3 / 10 to BRIGHTCOVE (BCOV). This can be considered as Overvalued.


How profitable is BRIGHTCOVE (BCOV) stock?

BRIGHTCOVE (BCOV) has a profitability rating of 3 / 10.


What is the valuation of BRIGHTCOVE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRIGHTCOVE (BCOV) is 89 and the Price/Book (PB) ratio is 2.11.


Can you provide the financial health for BCOV stock?

The financial health rating of BRIGHTCOVE (BCOV) is 4 / 10.